Email: info@BSBortho.com
Under
a provisions coverage program, TRICARE announced that Platelet Rich
Plasma (PRP) Injections are approved for a fiver-year period (Effective
Oct. 1, 2019 through Sept. 30, 2024).
TRICARE may cover PRP injections if you're diagnosed with:
Pre-authorization may be required for services and supplies in the program. It doesn't matter which TRICARE plan you're using. Provisional coverage for any approved service or supply can last up to five years, but may end before five years with timely notification of when it will end. There is also a chance that this service becomes a permanent TRICARE benefit.
Platelet Rich Plasma (PRP) Therapy is a minimally invasive non-surgical treatment that promotes healing without surgery. Platelets are a specialized type of blood cells that are involved in injury healing. With PRP, a concentrated platelet solution is injected into the injured area to stimulate healing.
There are numerous clinical studies showing PRP promotes healing in a variety of orthopedic injuries, and may eliminate the need for more aggressive treatments, such as long-term medications or surgery.
We use musculoskeletal ultrasound to identify the injured tendon, ligament or joint. Ultrasound is then used to guide the needle for the injection.
Dr. Sussman is published in peer-review journals on the use of
regenerative
medicine and platelet rich plasma injection, including on the role of
rehabilitation after regenerative injections. Boston Sports &
Biologics has experience working with TRICARE to get these injections
approved.
One of the best-studied treatments for tennis elbow is platelet rich plasma (PRP) injections. PRP is performed in the office, involves taking blood from a vein in the arm, concentrating the platelets in a centrifuge and injecting the PRP in to the tears within the tendon.
Unlike cortisone injections, PRP should not wear off and will hopefully heal the tendon. Learn more here.
Platelet-rich plasma (PRP) treatments can be used to help managed osteoarthritis pain and tendon injury. The use of PRP is becoming increasingly common in medical practice, but not all PRP is the same. Learn more here.
To schedule a consultation and learn if you are a candidate, call to schedule a consultation:
A recent study showed that the Tenex procedure was successful in 87.7% of the patients with tennis elbow and PRP effective in 84.6% of patients. In patients with tennis elbow (lateral epicondylitis) that have not
Read MoreA tenotomy under ultrasound guidance using the Tenex device has been shown to be a viable and effective procedure for patients with tennis elbow regardless of the severity of the tendon pathology. This study found that
Read More